B
Biomarker Technologies
Advanced genomic solutions with real-time optical chromosome conformation capture and high-throughput sequencing technologies
About Biomarker Technologies
Biomarker Technologies is a leading genomics company specializing in advanced sequencing and bioinformatics solutions. The company operates in the biotechnology sector, serving a diverse range of clients including academic researchers, pharmaceutical companies, and agricultural firms. Biomarker Technologies leverages cutting-edge technologies such as PacBio single molecule real-time sequencing, BioNano optical mapping, and Hi-C high-throughput chromosome conformation capture to provide comprehensive genomic insights. The business model is centered around offering high-precision genomic data and analysis services, which are critical for research and development in various fields including genetics, agriculture, and medicine. Revenue is generated through service contracts, project-based collaborations, and proprietary technology licensing.
Source: Dealroom company dataAt a glance
- Founded
- 2009
- Headquarters
- Shunyi District, China
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
- GMGuoke Jiahe (Beijing) Investment Management
- RCRenhe Capital
CD Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biomarker Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biomarker Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.